An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.
In 1889, German physiologists Oskar Minkowski and Joseph von Merin experimented by surgically removing the pancreas from a healthy dog to investigate its role in digestion. Post-surgery, they observed ...
In a small subset of those patients, the combination resulted in a strong response with tumor shrinkage and no disease ...
Approximately 1 in 56 men and 1 in 60 women will be diagnosed with pancreatic cancer at some point in their lives, and Pennsylvania has slightly higher rates ...
RenovoRx, Inc. ("RenovoRx” or the "Company”) (Nasdaq: RNXT), a life sciences company developing novel targeted oncology therapies and offering RenovoCath, a novel, FDA-cleared local drug-delivery ...
On November 27, 50% of all pizza sales will benefit the Pancreatic Cancer Action Network’s Purple Stride Walk, which is in ...
Children diagnosed with this disease barely survive past their first year. This is, however, not the case for baby Arianna.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback